MAPT and Alzheimer disease: To assess the seeding activity of the brain extracts by seeded-tau aggregation assay in cultured cells, we treated HEK-293FT/HA-3R-tau151-391 with various amounts of AD brain (case 2) extract for 42 h and analyzed RIPA-insoluble and -soluble tau with Western blots.